OBJECTIVE	1 ) To characterize the variability of multiple-dose halofantrine pharmacokinetics over time in healthy adults , 2 ) to correlate the pharmacodynamic measure electrocardiographic ( ECG ) QT interval with ( + ) - and ( - ) - halofantrine plasma concentration and 3 ) to evaluate the safety and tolerance of halofantrine hydrochloride given over time to healthy adults .\